Young Kwon
2019
In 2019, Young Kwon earned a total compensation of $1.5M as Chief Business Officer at Momenta Pharmaceuticals, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $184,800 |
|---|---|
| Option Awards | $873,896 |
| Salary | $440,000 |
| Other | $13,872 |
| Total | $1,512,568 |
Kwon received $873.9K in option awards, accounting for 58% of the total pay in 2019.
Kwon also received $184.8K in non-equity incentive plan, $440K in salary and $13.9K in other compensation.
Rankings
In 2019, Young Kwon's compensation ranked 7,277th out of 13,971 executives tracked by ExecPay. In other words, Kwon earned more than 47.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,277 out of 13,971 | 48th |
Division Manufacturing | 2,799 out of 5,695 | 51st |
Major group Chemicals And Allied Products | 1,042 out of 2,194 | 53rd |
Industry group Drugs | 886 out of 1,880 | 53rd |
Industry Biological Products, Except Diagnostic Substances | 205 out of 389 | 47th |
Pay ratio
| Young Kwon's Pay | $1,512,568 |
|---|---|
| Median Employee's Pay | $210,742 |
| Pay Ratio | 7to 1 |
In 2019, the annual total compensation of Young Kwon was $1,512,568.
The annual total compensation of the median employee at Momenta Pharmaceuticals was $210,742.
The ratio of Young Kwon's pay to the pay of median employee was therefore 7 to one.
Source: SEC filing on April 24, 2020.
Kwon's colleagues
We found four more compensation records of executives who worked with Young Kwon at Momenta Pharmaceuticals in 2019.